No valuation for NewBridge Pharmaceuticals is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($4.0M) and the funding record below are the closest available signals.
- ·Watch NewBridge Pharmaceuticals: the Monday email on marks, rounds and moves
NewBridge Pharmaceuticals funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| — | Early Stage VC | $4.0M | ▮ | ▮ |
Membership and data by Private Market View
How much has NewBridge Pharmaceuticals raised?
NewBridge Pharmaceuticals has raised $4 million across 1 recorded round. The largest was a $4 million early-stage round.
How NewBridge Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For NewBridge Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about NewBridge Pharmaceuticals
- How much has NewBridge Pharmaceuticals raised?
- NewBridge Pharmaceuticals has raised $4.0M in total funding across 1 recorded rounds.